TY - JOUR
T1 - Psychological measures of patient’s decision-making for prenatal genetic testing
AU - Herrera, Kimberly M.
AU - Milone, Gina
AU - Davis, Jay A.
AU - Persad, Malini D.
AU - Dinglas, Cheryl
AU - Heiselman, Cassandra
AU - Buckley, Ayisha
AU - Garretto, Diana
AU - Pastore, Lisa M.
N1 - Publisher Copyright:
© 2020 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2022
Y1 - 2022
N2 - Objective: To use a questionnaire to determine the levels of maternal decision-related distress, clarity of the pros and cons, and certainty when considering prenatal genetic diagnostic testing; and to assess the relationship between these constructs and patient characteristics. Method: Cross-sectional study. Voluntary, anonymous questionnaires distributed 2017–2019 to women referred for invasive prenatal genetic testing. Excluded: English or Spanish illiterate. Maternal characteristics were collected. Questions evaluated distress, decisional certainty, and decisional clarity on a 5-point Likert scale (range: 0 = low/uncertain/unclear to 4 = high/certain/clear). Analysis: non-parametric Kruskal–Wallis, correlation statistics, and ANOVA. Results: Forty-four female patients completed it. Most were married, white, Catholic, and multiparous. 58% had already made a testing decision. Patients expressed low distress levels (mean 1.18 ± 0.80) and expressed high decisional certainty (mean 3.28 ± 0.76) and clarity (mean 3.30 ± 0.99). Decisional certainty and clarity were positively correlated (r = 0.47, p <.01), whereas distress was negatively correlated with decisional certainty (r = −0.8136, p <.0005) and decisional clarity (r = −0.49, p =.007). No significant differences by religion or parity. Greater distress (p <.05) and less decisional clarity (p =.07) occurred between those still debating testing vs those who had decided. Conclusions: Higher maternal distress scores were associated with lower decisional certainty and decisional clarity in women considering prenatal genetic testing.
AB - Objective: To use a questionnaire to determine the levels of maternal decision-related distress, clarity of the pros and cons, and certainty when considering prenatal genetic diagnostic testing; and to assess the relationship between these constructs and patient characteristics. Method: Cross-sectional study. Voluntary, anonymous questionnaires distributed 2017–2019 to women referred for invasive prenatal genetic testing. Excluded: English or Spanish illiterate. Maternal characteristics were collected. Questions evaluated distress, decisional certainty, and decisional clarity on a 5-point Likert scale (range: 0 = low/uncertain/unclear to 4 = high/certain/clear). Analysis: non-parametric Kruskal–Wallis, correlation statistics, and ANOVA. Results: Forty-four female patients completed it. Most were married, white, Catholic, and multiparous. 58% had already made a testing decision. Patients expressed low distress levels (mean 1.18 ± 0.80) and expressed high decisional certainty (mean 3.28 ± 0.76) and clarity (mean 3.30 ± 0.99). Decisional certainty and clarity were positively correlated (r = 0.47, p <.01), whereas distress was negatively correlated with decisional certainty (r = −0.8136, p <.0005) and decisional clarity (r = −0.49, p =.007). No significant differences by religion or parity. Greater distress (p <.05) and less decisional clarity (p =.07) occurred between those still debating testing vs those who had decided. Conclusions: Higher maternal distress scores were associated with lower decisional certainty and decisional clarity in women considering prenatal genetic testing.
KW - Prenatal genetic testing;
KW - amniocentesis;
KW - patient understanding
KW - screening;
UR - https://www.scopus.com/pages/publications/85096296295
U2 - 10.1080/14767058.2020.1847074
DO - 10.1080/14767058.2020.1847074
M3 - Article
AN - SCOPUS:85096296295
SN - 1476-7058
VL - 35
SP - 4130
EP - 4136
JO - Journal of Maternal-Fetal and Neonatal Medicine
JF - Journal of Maternal-Fetal and Neonatal Medicine
IS - 21
ER -